
Noramco Invests $25M in Halo Pharma’s Whippany Facility for Sterile Injectables
Noramco Group Announces $25 Million Investment in Halo Pharma’s Whippany Facility for Sterile Injectable Manufacturing The Noramco Group, a prominent North American provider of integrated Active Pharmaceutical Ingredient (API) and drug product supply chain services, has made a strategic $25…